What Does Full FDA Approval of Moderna COVID Vaccine Mean? Asks Association of American Physicians and Surgeons (AAPS)
02 févr. 2022 10h16 HE
|
Association of American Physicians and Surgeons
TUCSON, Ariz., Feb. 02, 2022 (GLOBE NEWSWIRE) -- The FDA has granted full approval to Moderna’s messenger RNA (mRNA) COVID19 shot, Spikevax™, for persons age 18 and older. There are now two approved...
4BIO Capital Portfolio Company Carisma to Collaborate with Moderna to Develop in vivo Engineered Chimeric Antigen Receptor Monocytes (CAR-M) for Oncology
10 janv. 2022 13h00 HE
|
4Bio Capital
Press Release 4BIO Capital Portfolio Company Carisma to Collaborate with Moderna to Develop in vivo Engineered Chimeric Antigen Receptor Monocytes (CAR-M) for Oncology Collaboration will combine...
4BIO Capital Portfolio Company Carisma to Collaborate with Moderna to Develop in vivo Engineered Chimeric Antigen Receptor Monocytes (CAR-M) for Oncology
10 janv. 2022 13h00 HE
|
4Bio Capital
Press Release 4BIO Capital Portfolio Company Carisma to Collaborate with Moderna to Develop in vivo Engineered Chimeric Antigen Receptor Monocytes (CAR-M) for Oncology Collaboration will combine...
Scientists & Academics, led by PrEP4All and Right to Health Action, demand global vaccine program at homes of Biden Chief of Staff and Moderna CEO
29 sept. 2021 17h30 HE
|
PrEP4All
“Biden’s failed COVID summit was our last straw,” say scientists who held dual press conferences at the homes of White House Chief of Staff Ron Klain and Moderna CEO Stephane Bancel. Speakers at both...
Dyadic and Sorrento Announce Binding Term Sheet to License Dyadic’s Lead COVID-19 Vaccine Candidate “DYAI-100” and C1 Technology for Protein-Based Coronavirus Vaccines and Therapeutics
11 août 2021 08h35 HE
|
Dyadic International, Inc.
Sorrento to obtain exclusive rights in North and South America, Europe, major Asian countries (including Greater China and Japan) and certain other countries to utilize Dyadic’s C1 technology for the...
Global WholeHealth Partners Corp (GWHP-OTC) Acquires Rights to Distribute & Sell a 3rd COVID-19 Vaccine - Moderna
29 juin 2021 07h00 HE
|
Global WholeHealth Partners Corp.
Moderna Generated $1.94 Billion in Revenue During the First Quarter, with $1.73 Billion Coming from Its COVID-19 Shot Company Now Has the Rights to Distribute & Sell Three of the Most Popular...
Odyssey Group International Welcomes World Cup Winner Abby Wambach to Sports Advisory Board
30 mars 2021 07h29 HE
|
Odyssey Group International
Irvine, CA, March 30, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing...
Pregnant Patients Should Weigh Risk of COVID Jab, States Association of American Physicians and Surgeons (AAPS)
04 mars 2021 13h39 HE
|
Association of American Physicians and Surgeons
TUCSON, Ariz., March 04, 2021 (GLOBE NEWSWIRE) -- The American College of Obstetricians and Gynecologists (ACOG) and the Society for Maternal-Fetal Medicine (SMFM) have recommended that COVID-19...
Lui Franciosi To Monitor the Safety and Efficacy of COVID-19 Vaccines and Treatments
06 janv. 2021 13h14 HE
|
Franciosi Consulting Ltd.
VANCOUVER, British Columbia, Jan. 06, 2021 (GLOBE NEWSWIRE) -- Lui Franciosi is pleased to announce that Franciosi Consulting Ltd. will be monitoring the safety and efficacy of vaccines and...
Franciosi Consulting Assessing New Potential Treatments for Asthma and COPD
29 déc. 2020 17h20 HE
|
Franciosi Consulting Ltd.
VANCOUVER, British Columbia, Dec. 29, 2020 (GLOBE NEWSWIRE) -- Lui Franciosi is pleased to announce that Franciosi Consulting Ltd. will be assessing the use of glycosaminoglycans (GAGs) for the...